Cinctive Capital Management’s Medtronic MDT Stock Holding History

Cinctive Capital Management’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.83M	Buy	32,710 +11,696	+56%	+$1.12M	0.18%	172
2025 Q4	$2.02M	Buy	+21,014	New	+$2.04M	0.11%	211
2022 Q2	–	Sell	-75,583	Closed	-$8.39M	–	587
2022 Q1	$8.39M	Buy	+75,583	New	+$7.99M	0.31%	100
2021 Q4	–	Sell	-89,372	Closed	-$11.2M	–	608
2021 Q3	$11.2M	Buy	89,372 +82,297	+1,163%	+$10.7M	0.55%	33
2021 Q2	$878K	Sell	7,075 -37,216	-84%	-$4.67M	0.04%	379
2021 Q1	$5.23M	Buy	44,291 +28,864	+187%	+$3.38M	0.32%	108
2020 Q4	$1.81M	Sell	15,427 -94,156	-86%	-$10.4M	0.15%	234
2020 Q3	$11.4M	Buy	+109,583	New	+$11M	1%	9

Other funds holding MDT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cinctive Capital Management's MDT Position: Q1 2026 in Review

Cinctive Capital Management increased its Medtronic (MDT) stake by 56% in Q1 2026, buying an estimated $1.12M and bringing the position to 32,710 shares worth $2.83M. The position accounts for 0.18% of the portfolio, ranked #172.

Cinctive Capital Management first reported a position in MDT in Q3 2020 and has held it in 8 quarters since. The position peaked at $11.4M in Q3 2020. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

Cinctive Capital Management held 32,710 shares of Medtronic worth $2.83M as of Q1 2026.
Cinctive Capital Management bought 11,696 Medtronic shares in Q1 2026, an estimated $1.12M.
Medtronic made up 0.18% of Cinctive Capital Management's portfolio in Q1 2026, its #172 holding.
Cinctive Capital Management first reported a position in Medtronic in Q3 2020 and has held it in 8 quarters since.
Cinctive Capital Management's Medtronic position peaked at $11.4M in Q3 2020.
2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Cinctive Capital Management's 13F filing for Q1 2026, filed 15 May 2026.